Skip to content
Research Article Open access CC BY 4.0

Serum Expression Levels of miR-141 and miR-215 for Differentiation between Liver Cirrhosis, Chronic Hepatitis C and Hepatocellular Carcinoma Patients

Sahar A. M. Ali, Ziab Z. Alahmady, Hussain A. Yamany, Amr M. Abul-Fotouh

Microbiology Research Journal International · pp. 1–12 · Published 16 Jun 2017

10.9734/MRJI/2017/34134

Abstract

Objectives: To evaluate the ability of estimation of serum expression levels of micro RNA (miR-141 and miR-215 to differentiate between liver cirrhosis, chronic hepatitis C (CHC) and hepatocellular carcinoma (HCC) patients. Patients and Methods: The study included 25 liver cirrhosis patients, 25 CHC patients, 25 HCC patients and 15 volunteers (Control group). All patients underwent clinical examination, preliminary investigations and radiological workup. Fasting blood samples were withdrawn from all patients and controls for estimation of serum levels of α-fetoprotein (AFP), quantitative PCR estimation of HCV RNA titers and real-time PCR quantitation of serum expression levels of miR-215 and miR-215 -141. Results: Serum AFP levels were significantly higher in HCC patients than cirrhosis and CHC patients. Estimated serum expression levels of miR-215 were significantly higher in CHC and HCC patients compared to both controls and cirrhosis, while serum expression levels of miR-141 were significantly lower in HCC patients compared to controls and cirrhosis patients and in CHC patients than controls. Estimated HCV viral load in CHC patients showed positive significant correlation with serum expression level of miR-215, while showed non-significant correlation with miR-141. Estimated serum levels of miR-215 and miR-141 could differentiate hepatic patients and controls with AUC= 0.872 and 0.250, respectively. Whereas, estimated serum levels of miR-215 could differentiate between cirrhosis and CHC patients with AUC= 0.899. Estimated serum levels of miR-215 and miR-141 also could be used to identify HCC patients out of hepatic disease patients with AUC of 0.818 and 0.351, respectively. Conclusion: Serum expression levels of miR-215 and miR-141 could be used to identify hepatic disease patients with high positive predictive value (PPV) especially miR-215. miR-215 can differentiate between cirrhosis and CHC patients and correlated with HCV load. Serum levels of both miRs could assure diagnosis of HCC with high PPV.

Hepatic diseases miR-215 miR-141 HCC patients detection

References (34)

  1. 1 Diagnosis, management, and treatment of hepatitis C: An update # † ‡ [DOI]
  2. 2 miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response [DOI]
  3. 3 Chronic hepatitis C and liver fibrosis [DOI]
  4. 4 MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma [DOI]
  5. 5 Non-invasive diagnosis of advanced fibrosis and cirrhosis [DOI]
  6. 6 Circulating microRNAs: novel biomarkers for cardiovascular diseases [DOI]
  7. 7 MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets [DOI]
  8. 8 Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication [DOI]
  9. 9 Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver [DOI]
  10. 10 Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma [DOI]
  11. 11 Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma [DOI]
  12. 12 microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer [DOI]
  13. 13 Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection [DOI]
  14. 14 MiR-141 Suppresses the Migration and Invasion of HCC Cells by Targeting Tiam1 [DOI]
  15. 15 Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma [DOI]
  16. 16 Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma [DOI]
  17. 17 Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma [DOI]
  18. 18 Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway [DOI]
  19. 19 Serum miR-224 Reflects Stage of Hepatocellular Carcinoma and Predicts Survival [DOI]
  20. 20 Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage [DOI]
  21. 21 Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance [DOI]
  22. 22 Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma [DOI]
  23. 23 MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor [DOI]
  24. 24 Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer [DOI]
  25. 25 Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma [DOI]
  26. 26 Severity of Hepatitis C Virus (Genotype-3) Infection Positively Correlates with Circulating MicroRNA-122 in Patients Sera [DOI]
  27. 27 Noninvasive Measures of Liver Fibrosis and Severity of Liver Disease.
  28. 28 MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues [DOI]
  29. 29 The significance of serum AFP cut-off values, 20 and 400 ng/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of difference. [DOI]
  30. 30 Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients [DOI]
  31. 31 [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
  32. 32 Prolonged Negative HCV-RNA Status Led to a Good Outcome in Chronic Hepatitis C Patients with Genotype 1b and Super-High Viral Load [DOI]
  33. 33 Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core protein [DOI]
  34. 34 Experimental and Therapeutic Medicine [DOI]

Cited by 7

Role of circulating microRNA-21 and microRNA-215 in the diagnosis of hepatitis C related hepatocellular carcinoma.

Zeinab S. Abdelkhalek, M. Abdalla, M. Fathy · Journal of Infection in Developing Countries · 2021

Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation

Areeg M. Dabbish, Hana M Abdelzaher, Moustafa Abohawya · Cancers · 2021

miRNA-141 and its target long non-coding RNA HOTAIR as diagnostic marker in hepatocellular carcinoma on top of hepatitis C virus

O. Shaker, Ahmed M Khairy, R. M. Ali · 2020

Crosstalk between miR‐215 and epithelial‐mesenchymal transition specific markers (E‐cadherin and N‐cadherin) in different stages of chronic HCV Infection

Nermeen M Omran, S. El-Sherbini, O. Hegazy · Journal of Medical Virology · 2019

Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma

L. Ali, A. Higazi, Hend Moness · Clinical and Experimental Gastroenterology · 2019

miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB Signaling

H. Tian, Zhen-Kun He · Yonsei medical journal · 2018

Showing 6 of 7 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

27

Page views

0

PDF downloads

2

Outbound clicks

7

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.